Your browser doesn't support javascript.
loading
Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome.
Aalbers, Anna M; van Daele, Paul L A; Dalm, Virgil A S H; Valk, Peter J M; Raaijmakers, Marc H G P.
Affiliation
  • Aalbers AM; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam The Netherlands.
  • van Daele PLA; Department of Internal Medicine, Division of Allergy & Clinical Immunology, and Department of Immunology, Erasmus MC University Medical Center Rotterdam Rotterdam the Netherlands.
  • Dalm VASH; Department of Internal Medicine, Division of Allergy & Clinical Immunology, and Department of Immunology, Erasmus MC University Medical Center Rotterdam Rotterdam the Netherlands.
  • Valk PJM; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam The Netherlands.
  • Raaijmakers MHGP; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam The Netherlands.
Hemasphere ; 8(8): e129, 2024 Aug.
Article in En | MEDLINE | ID: mdl-39081801
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: HemaSphere / Hemasphere Year: 2024 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: HemaSphere / Hemasphere Year: 2024 Document type: Article Country of publication: Estados Unidos